CD8A and neoplasm: Compared with the control group, the percentage of IFN-γ+ CD4+ or IFN-γ+ CD8+ T cells was significantly increased in tumor after treatment with either OX40 antibody, and the level of increase was similar between these two antibodies (Figures 5C).